Recent Press Releases

AVAC applauds President Biden and the US Senate in officially confirming Dr. John Nkengasong as the new US Global AIDS Coordinator leading the President’s Emergency Plan for AIDS Relief (PEPFAR), the largest funder of HIV/AIDS programming in the world. President Biden nominated and the Senate voted to confirm Nkengasong.

AVAC welcomes the US Food and Drug Administration (FDA) approval of injectable cabotegravir (CAB-LA, and brand name “Apretude”), the first injectable form of HIV pre-exposure prophylaxis (PrEP). As another form of HIV PrEP that does not require taking a daily pill, CAB-LA is a much-needed addition to a proven HIV prevention toolbox that now also includes male and female condoms, daily oral PrEP, voluntary medical male circumcision (VMMC) and the Dapivirine Vaginal Ring.

AVAC applauds the Biden-Harris Administration on the nomination of John Nkengasong, a bold and inspiring choice, as the next US Global AIDS Coordinator to head the President’s Emergency Plan for AIDS Relief (PEPFAR), one of the most dynamic and effective foreign assistance programs ever developed.

Worldwide, trans and gender-diverse (TGD) people face a highly disproportionate burden of HIV but are frequently and often systematically left out of HIV prevention research and responses. That ongoing exclusion is a major barrier to efforts to end the global HIV pandemic, according to No Data No More, a new HIV prevention manifesto written by TGD advocates from South Africa, Europe and the United States, with support and solidarity from AVAC. The embargoed report and materials are available here.